Siamab Therapeutics siamab.com


Public list: Pharma Startups (4732) Cancer Therapeutics (1137)

Siamab Therapeutics is a biopharmaceutical company developing cancer immunotherapies. Siamab has developed a platform of technologies that enable the discovery and development of therapeutic antibodies that bind to a class of carbohydrate antigens present in cancer cells.

Siamab Therapeutics is a biopharmaceutical company developing cancer immunotherapies. Siamab has developed a platform of technologies that enable the discovery and development of therapeutic antibodies that bind to a class of carbohydrate antigens pr...Show all

Company (Alive / Active)

Phone: 617-714-9773

Fax:

90 Bridge Street
Suite 100
Newton, 02458
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Siamab Therapeutics $10.5M Nov 8, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Siamab Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 12 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Glycan-interacting compounds and methods of use Jan 04, 2016 Jan 30, 2018 Patent
Compositions and methods for detecting cancer Dec 23, 2013 Aug 23, 2016 Patent
Glycan-interacting compounds Jan 21, 2016 Aug 16, 2016 Patent
Glycan-interacting compounds Oct 10, 2013 Mar 01, 2016 Patent
Glycan-interacting compounds Jul 11, 2016 Application
See all 9 patents